Carpmaels & Ransford expands in Germany & more…Keep up with what has been happening this week in our latest IP news round-up…

BioNTech and Pfizer strike back against GSK in London

After GSK sued the two manufacturers of the COVID-19 vaccine Comirnaty at the UPC and in Ireland, Pfizer and BioNTech are now seeking revocation of the related GSK patent at the UK High Court. Taylor Wessing, Powell Gilbert and Bird & Bird are once again involved in the proceedings.

Anthropic’s AI copyright settlement provides legal lessons

A judge in the US has refused to endorse a settlement reached in a case concerning mass claims of copyright infringement against an AI developer.

Carpmaels & Ransford expands in Germany with two litigation partner hires and larger Munich office

Carpmaels & Ransford welcomed two new litigation partners Niels Hölder and Mike Gruber, as the firm significantly expands its presence in Germany to meet demand for the firm’s contentious services in Europe, particularly at the Unified Patent Court (UPC).

Mewburn Ellis donate £300,000 to charity partnerships for 2025/2026 — over £1.3M donated since 2020

Today marks International Day of Charity (5 September) and since 2020, we’ve donated over £1.3M to charity so far, including £300K in 2025, through our Forward Community Programme Charity Fund reinforcing our belief that charity is not just a commitment, it’s part of who we are.

China leads global core digital economy patents in 2024

China ranked first worldwide in terms of the number of invention patent grants within the core industries of the digital economy in 2024, with a growth rate notably exceeding the global average, the country’s top intellectual property (IP) regulator said on Thursday.